SCHEMBL17597937

SCHEMBL17597937

O=C(Cn1cnc2cc(Cl)c(Cl)cc21)c1nn(C2CCCCO2)c2cc(Oc3cccnc3)ccc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 1/20 0.34
▸ CDK9 P50750 3/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.33
▸ METAP2 P50579 2/20 0.33
▸ NAMPT P43490 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ DGAT2 Q96PD7 1/20 0.32
▸ ACACB O00763 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ OPRK1 P41145 1/20 0.32
▸ UTS2R Q9UKP6 1/20 0.32
▸ PDE10A Q9Y233 1/20 0.32
▸ EGLN2 Q96KS0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17597441 0.84 METAP2 (0.38) PPARGMETAP2ABL1ACACBEGLN2
SCHEMBL17597840 0.80 METAP2 (0.40) PPARGMETAP2ABL1DGAT2ACACB
SCHEMBL17913308 0.77 IRAK4 (0.35) PPARGABL1EGLN2EGLN1GRM5
SCHEMBL17597511 0.77 DRD2 (0.38) PPARGFFAR4METAP2ALDH1A1EGLN2
SCHEMBL17597287 0.75 PPARG (0.40) PPARGFFAR4METAP2NAMPTALDH1A1
SCHEMBL17597319 0.74 ALDH1A1 (0.43) FFAR4ALDH1A1
SCHEMBL17597419 0.73 CA12 (0.37) PPARGFFAR4METAP2ALDH1A1GRM5
SCHEMBL17597779 0.71 CA12 (0.38) PPARGFFAR4METAP2ALDH1A1
SCHEMBL17597797 0.67 CNR2 (0.42) —
SCHEMBL17597812 0.66 DRD2 (0.39) PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016040764-A1 CARBONYL LINKED BICYCLIC HETEROARYL N-BENZIMIDAZOLES AND ANALOGS AS ANTIBIOTIC TOLERANCE INHIBITORS SPERO THERAPEUTICS, INC. (US) 2016-03-17 — — WO disclosed
Send feedback